Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

343 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Coincidence of 5q deletion and the JAK2V617F mutation: report of two patients with overlapping myelodysplastic and myeloproliferative features and review of the literature.
Bürki S, Shumilov E, Bonadies N, Flach J, Legros M, Banz Y, Oppliger-Leibundgut E, Fiedler M, Angelillo-Scherrer A, Rovo A, Bacher U. Bürki S, et al. Among authors: bacher u. Leuk Lymphoma. 2018 Sep;59(9):2233-2237. doi: 10.1080/10428194.2017.1416367. Epub 2018 Jan 3. Leuk Lymphoma. 2018. PMID: 29295644 Review. No abstract available.
Results of a multicenter prospective phase II trial investigating the safety and efficacy of lenalidomide in patients with myelodysplastic syndromes with isolated del(5q) (LE-MON 5).
Schuler E, Giagounidis A, Haase D, Shirneshan K, Büsche G, Platzbecker U, Nolte F, Götze K, Schlenk RF, Ganser A, Letsch A, Braulke F, Lübbert M, Bug G, Schafhausen P, Bacher U, Gattermann N, Wulfert M, Haas R, Germing U. Schuler E, et al. Among authors: bacher u. Leukemia. 2016 Jul;30(7):1580-2. doi: 10.1038/leu.2015.340. Epub 2015 Dec 15. Leukemia. 2016. PMID: 26668126 Clinical Trial. No abstract available.
Osteolytic lesions occur rarely in patients with B-CLL and may respond well to ibrutinib.
Shumilov E, Wulf G, Ströbel P, Hasenkamp J, Hellige N, Bleckmann A, Haase D, Braulke F, Jung W, Schanz J, Binder M, Trümper L, Bacher U. Shumilov E, et al. Among authors: bacher u. Leuk Lymphoma. 2016 Oct;57(10):2476-80. doi: 10.3109/10428194.2016.1151510. Epub 2016 Feb 25. Leuk Lymphoma. 2016. PMID: 26916814 No abstract available.
Chemotherapy-Based Stem Cell Mobilization Does Not Result in Significant Paraprotein Reduction in Myeloma Patients in the Era of Novel Induction Regimens.
Oyekunle A, Shumilov E, Kostrewa P, Burchert A, Trümper L, Wuchter P, Wulf G, Bacher U, Kröger N. Oyekunle A, et al. Among authors: bacher u. Biol Blood Marrow Transplant. 2018 Feb;24(2):276-281. doi: 10.1016/j.bbmt.2017.10.008. Epub 2017 Oct 13. Biol Blood Marrow Transplant. 2018. PMID: 29037891 Free article.
In Situ Validation of the Endothelial Cell Receptor GRP78 in a Case of Rhinocerebral Mucormycosis.
Shumilov E, Bacher U, Perske C, Mohr A, Eiffert H, Hasenkamp J, Trümper L, Wulf GG, Ströbel P, Ibrahim AS, Venkataramani V. Shumilov E, et al. Among authors: bacher u. Antimicrob Agents Chemother. 2018 Apr 26;62(5):e00172-18. doi: 10.1128/AAC.00172-18. Print 2018 May. Antimicrob Agents Chemother. 2018. PMID: 29483124 Free PMC article. No abstract available.
Current status and trends in the diagnostics of AML and MDS.
Shumilov E, Flach J, Kohlmann A, Banz Y, Bonadies N, Fiedler M, Pabst T, Bacher U. Shumilov E, et al. Among authors: bacher u. Blood Rev. 2018 Nov;32(6):508-519. doi: 10.1016/j.blre.2018.04.008. Epub 2018 Apr 27. Blood Rev. 2018. PMID: 29728319 Review.
Genetic alterations crossing the borders of distinct hematopoetic lineages and solid tumors: Diagnostic challenges in the era of high-throughput sequencing in hemato-oncology.
Shumilov E, Flach J, Pabst T, Fiedler M, Angelillo-Scherrer A, Trümper L, Joncourt R, Kohlmann A, Bacher U. Shumilov E, et al. Among authors: bacher u. Crit Rev Oncol Hematol. 2018 Jun;126:64-79. doi: 10.1016/j.critrevonc.2018.03.020. Epub 2018 Mar 29. Crit Rev Oncol Hematol. 2018. PMID: 29759569 Review.
Pitfalls in the molecular follow up of NPM1 mutant acute myeloid leukemia.
Bacher U, Porret N, Joncourt R, Sanz J, Aliu N, Wiedemann G, Jeker B, Banz Y, Pabst T. Bacher U, et al. Haematologica. 2018 Oct;103(10):e486-e488. doi: 10.3324/haematol.2018.192104. Epub 2018 Jun 14. Haematologica. 2018. PMID: 29903758 Free PMC article. No abstract available.
Critical evaluation of current molecular MRD strategies including NGS for the management of AML patients with multiple mutations.
Shumilov E, Flach J, Joncourt R, Porret N, Wiedemann G, Angelillo-Scherrer A, Trümper L, Fiedler M, Jeker B, Amstutz U, Pabst T, Bacher U. Shumilov E, et al. Among authors: bacher u. Hematol Oncol. 2019 Aug;37(3):319-322. doi: 10.1002/hon.2603. Epub 2019 Mar 28. Hematol Oncol. 2019. PMID: 30843248 Clinical Trial. No abstract available.
343 results